相关实验视频

Updated: Jul 22, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

工程增强的仿真抗原受体-T细胞疗法用于固体瘤

A Neeser¹, R Ramasubramanian¹, C Wang²

¹Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia.

Immuno-oncology technology

|July 24, 2023

概括

化学抗原受体 (CAR) -T细胞疗法对血液癌症有希望,但在固体瘤中面临挑战. 如基因电路和生物材料等生物工程策略正在开发中,以提高CAR-T细胞在固体瘤治疗中的疗效.

科学领域:

免疫治疗是一种免疫疗法.
生物技术是生物技术.
在瘤学瘤学.

背景情况:

化学抗原受体 (CAR) -T细胞疗法已获得FDA对白血病和淋巴瘤的批准,在血液恶性瘤中显示出有效性.
将CAR-T细胞疗法的成功转化为固体瘤仍然是临床实践和临床前研究中的重大挑战.

研究的目的:

审查最近的生物工程策略,旨在加强对固体瘤的CAR-T细胞治疗.
突出解决阻碍CAR-T细胞在固体瘤环境中的疗效障碍的方法.

主要方法:

关于CAR-T细胞治疗生物工程策略的文献综述.
专注于针对性单基因干扰,遗传电路,细胞因子工程和交互式生物材料.
分析这些策略如何克服固体瘤的挑战.

主要成果:

生物工程方法为改善固体瘤中CAR-T细胞功能提供了新的工具.
讨论的策略包括遗传电路,细胞因子工程和生物材料.
这些进展旨在提高CAR-T细胞疗法的安全性和有效性.

结论:

生物工程策略对于克服CAR-T细胞治疗固体瘤特异性障碍至关重要.
这些方法有可能实现强大而持久的治疗反应.
生物工程的进一步发展将是实现CAR-T细胞对固体瘤的全部潜力的关键.

关键词:

在CART-T中,我们可以使用CAR-T.生物材料是一种生物材料.工程化细胞因子是什么基因电路是基因电路.合成生物学合成生物学疫苗疫苗疫苗疫苗

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...